{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:40:12Z","timestamp":1789094412250,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.colsurfb.2024.113996","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T06:29:44Z","timestamp":1716877784000},"page":"113996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Developing oxaliplatin and IL-15 Co-carried gels as drug depots to enable triple-interlocked combination therapy for colorectal cancer"],"prefix":"10.1016","volume":"241","author":[{"given":"Dandan","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqian","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiali","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenkun","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7973","key":"10.1016\/j.colsurfb.2024.113996_bib1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41586-023-06348-2","article-title":"Rewiring cancer drivers to activate apoptosis","volume":"620","author":"Gourisankar","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.colsurfb.2024.113996_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113283","article-title":"Targeted delivery of pexidartinib to tumor-associated macrophages via legumain-sensitive dual-coating nanoparticles for cancer immunotherapy","volume":"226","author":"Liang","year":"2023","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1","key":"10.1016\/j.colsurfb.2024.113996_bib3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12951-022-01330-y","article-title":"Engineered extracellular vesicles: potentials in cancer combination therapy","volume":"20","author":"Chen","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.colsurfb.2024.113996_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114732","article-title":"Combination of FAK inhibitor and cytokine-induced killer cell therapy: an alternative therapeutic strategy for patients with triple-negative breast cancer","volume":"163","author":"Wu","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.colsurfb.2024.113996_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113597","article-title":"A novel self-assembled nucleobase-nanofiber platform of CDN to activate the STING pathway for synergistic cancer immunotherapy","volume":"232","author":"Dong","year":"2023","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1","key":"10.1016\/j.colsurfb.2024.113996_bib6","first-page":"142","article-title":"A review on nano-based drug delivery system for cancer chemoimmunotherapy","volume":"12","author":"Mu","year":"2020","journal-title":"Nanomicro Lett."},{"issue":"2","key":"10.1016\/j.colsurfb.2024.113996_bib7","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1021\/acsnano.2c00462","article-title":"Nano-ultrasonic contrast agent for chemoimmunotherapy of breast cancer by immune metabolism reprogramming and tumor autophagy","volume":"16","author":"Yang","year":"2022","journal-title":"ACS Nano"},{"issue":"28","key":"10.1016\/j.colsurfb.2024.113996_bib8","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1200\/JCO.23.01323","article-title":"Chemoimmunotherapy for untreated lung cancer brain metastases: systemic before local therapy?","volume":"41","author":"Lu","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.colsurfb.2024.113996_bib9","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/gutjnl-2021-326581","article-title":"Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment","volume":"72","author":"Fan","year":"2023","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.colsurfb.2024.113996_bib10","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.cell.2022.03.033","article-title":"Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche","volume":"185","author":"Baldominos","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.colsurfb.2024.113996_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115004","article-title":"Driving natural killer cell-based cancer immunotherapy for cancer treatment: an arduous journey to promising ground","volume":"165","author":"Jiang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"7806","key":"10.1016\/j.colsurfb.2024.113996_bib12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41586-020-2229-5","article-title":"Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I","volume":"581","author":"Yamamoto","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.colsurfb.2024.113996_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","article-title":"Neoantigens: promising targets for cancer therapy","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"issue":"4","key":"10.1016\/j.colsurfb.2024.113996_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","article-title":"Immunogenic cell stress and death","volume":"23","author":"Kroemer","year":"2022","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.113996_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41568-020-00308-y","article-title":"The rediscovery of platinum-based cancer therapy","volume":"21","author":"Rottenberg","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.colsurfb.2024.113996_bib16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12253-018-0444-2","article-title":"IL-2 and IL-15 induced NKG2D, CD158a and CD158b expression on T, NKT- like and NK Cell lymphocyte subsets from regional lymph nodes of melanoma patients","volume":"26","author":"Vuletic","year":"2020","journal-title":"Pathol. Oncol. Res."},{"issue":"8","key":"10.1016\/j.colsurfb.2024.113996_bib17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41568-020-0272-z","article-title":"The cancer-natural killer cell immunity cycle","volume":"20","author":"Huntington","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.colsurfb.2024.113996_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113998","article-title":"Surface-engineered nanoparticles in cancer immune response and immunotherapy: current status and future prospects","volume":"157","author":"Chen","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.colsurfb.2024.113996_bib19","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1182\/blood.2021011532","article-title":"Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy","volume":"139","author":"Berrien-Elliott","year":"2022","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.colsurfb.2024.113996_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/cells12111496","article-title":"Special issue new developments in natural killer cells for immunotherapy","volume":"12","author":"Zimmer","year":"2023","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.colsurfb.2024.113996_bib21","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96219","article-title":"Continuous treatment with IL-15 exhausts human NK cells via a metabolic defect","volume":"3","author":"Felices","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.colsurfb.2024.113996_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114503","article-title":"Immunogenic cell death inducer peptides: a new approach for cancer therapy, current status and future perspectives","volume":"161","author":"Aria","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.113996_bib23","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1038\/s41467-023-38014-6","article-title":"Temperature sensitive liposome based cancer nanomedicine enables tumour lymph node immune microenvironment remodelling","volume":"14","author":"Fu","year":"2023","journal-title":"Nat. Commun."},{"issue":"21","key":"10.1016\/j.colsurfb.2024.113996_bib24","article-title":"A tumor microenvironments-adapted Polypeptide Hydrogel\/Nanogel composite boosts antitumor molecularly targeted inhibition and immunoactivation","volume":"34","author":"Li","year":"2022","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.113996_bib25","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/s41467-022-29121-x","article-title":"Thermosensitive hydrogel releasing nitric oxide donor and anti-CTLA-4 micelles for anti-tumor immunotherapy","volume":"13","author":"Kim","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.colsurfb.2024.113996_bib26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2016.07.022","article-title":"Development and evaluation of oxaliplatin and irinotecan co-loaded liposomes for enhanced colorectal cancer therapy","volume":"238","author":"Zhang","year":"2016","journal-title":"J. Control Release"},{"issue":"1","key":"10.1016\/j.colsurfb.2024.113996_bib27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1208\/s12248-015-9828-3","article-title":"Thermosensitive hydrogel co-loaded with gold nanoparticles and doxorubicin for effective chemoradiotherapy","volume":"18","author":"Li","year":"2016","journal-title":"AAPS J."},{"key":"10.1016\/j.colsurfb.2024.113996_bib28","unstructured":"Jakimov D., Bogdanovi\u0107 V., Djuran M.I., Juri\u0161i\u0107 V., Koji\u0107 V., In Vitro Antitumor Activity of Carboplatin and Analogues, Journal of Coordination Chemistry 1-13."},{"issue":"19","key":"10.1016\/j.colsurfb.2024.113996_bib29","doi-asserted-by":"crossref","first-page":"22213","DOI":"10.1021\/acsami.1c03709","article-title":"Lymph node delivery strategy enables the activation of cytotoxic t lymphocytes and natural killer cells to augment cancer immunotherapy","volume":"13","author":"Jiang","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"3","key":"10.1016\/j.colsurfb.2024.113996_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.721","article-title":"A guide to flow cytometry: components, basic principles, experimental design, and cancer research applications","volume":"3","author":"El-Hajjar","year":"2023","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.colsurfb.2024.113996_bib31","doi-asserted-by":"crossref","unstructured":"McKinnon K.M., Flow Cytometry: an Overview, Curr Protoc Immunol 120 (2018) 5 1 1-5 1 11.","DOI":"10.1002\/cpim.40"},{"issue":"9","key":"10.1016\/j.colsurfb.2024.113996_bib32","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/14789450.2020.1845654","article-title":"Multiomic analysis of cytokines in immuno-oncology","volume":"17","author":"Jurisic","year":"2020","journal-title":"Expert Rev. Proteom."},{"key":"10.1016\/j.colsurfb.2024.113996_bib33","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jconrel.2023.04.011","article-title":"Enhancing anti-tumor immunity through liposomal oxaliplatin and localized immunotherapy via STING activation","volume":"357","author":"Gu","year":"2023","journal-title":"J. Control Release"},{"key":"10.1016\/j.colsurfb.2024.113996_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115573","article-title":"Delivery of oxaliplatin to colorectal cancer cells by folate-targeted UiO-66-NH(2)","volume":"423","author":"Hashemzadeh","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"10","key":"10.1016\/j.colsurfb.2024.113996_bib35","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1016\/j.bmc.2015.03.044","article-title":"Promising antiproliferative platinum(II) complexes based on imidazole moiety: synthesis, evaluation in HCT-116 cancer cell line and interaction with Ctr-1 Met-rich domain","volume":"23","author":"Ferri","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.113996_bib36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/CMR.0000000000000126","article-title":"In-vitro activation of natural killer cells from regional lymph nodes of melanoma patients with interleukin-2 and interleukin-15","volume":"25","author":"Vuletic","year":"2015","journal-title":"Melanoma Res."},{"key":"10.1016\/j.colsurfb.2024.113996_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102614","article-title":"Novel targets for immune-checkpoint inhibition in cancer","volume":"120","author":"Borgeaud","year":"2023","journal-title":"Cancer Treat. Rev."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776524002558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776524002558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T01:13:03Z","timestamp":1722042783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776524002558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":37,"alternative-id":["S0927776524002558"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2024.113996","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developing oxaliplatin and IL-15 Co-carried gels as drug depots to enable triple-interlocked combination therapy for colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2024.113996","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113996"}}